Vivendi


A disappointing Q4 and a slowdown in UMG's revenue growth

04/03/21 -"Vivendi released indeed a not so good Q4. UMG revenues were up by only 5.4% yoy and lfl in Q4 (vs +6.1% in Q3 and +12% in Q1 before the COVID-19 crisis). So we have to remain cautious about a ..."

Pages
59
Language
English
Published on
04/03/21
You may also be interested by these reports :
16/04/24
Wise’s Q4 24 trading update once again showed very strong NII but very soft VPC. Wise continues to benefit from high interest rates and constraints ...

15/04/24
At a dead end

14/04/24
Our 2025 EPS estimates have been sharply reduced due to the sale of Kinnevik’s stake in Tele2, which is expected to take place in 2024. As a result, ...

12/04/24
A smart investor who bought Atlas Copco shares (Sweden, Reduce) at the turn of the century would have enjoyed an annual price return of +13.5% and ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO